These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Review of tissue plasminogen activator, ischemic stroke, and potential legal issues. Liang BA; Lew R; Zivin JA Arch Neurol; 2008 Nov; 65(11):1429-33. PubMed ID: 19001160 [TBL] [Abstract][Full Text] [Related]
16. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke. Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152 [TBL] [Abstract][Full Text] [Related]
17. The hard way to acute stroke treatment. Sironi L; Gelosa P; Tremoli E; Cimino M J Hypertens; 2008 Dec; 26(12):2274-5. PubMed ID: 19008704 [No Abstract] [Full Text] [Related]
18. Tissue plasminogen activator use in a patient with acute ischemic stroke coexisting with meningioma. Hsieh HC; Chen CH Clin Neurol Neurosurg; 2009 Jul; 111(6):562-3. PubMed ID: 19200644 [No Abstract] [Full Text] [Related]
19. Acute stroke: we have the treatments and we have the evidence--we need to use them. Quinn TJ; Dawson J; Lees KR Crit Care; 2007; 11(2):124. PubMed ID: 17466085 [TBL] [Abstract][Full Text] [Related]
20. Methods and processes for the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial. Hertzberg V; Ingall T; O'Fallon W; Asplund K; Goldfrank L; Louis T; Christianson T Clin Trials; 2008; 5(4):308-15. PubMed ID: 18697845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]